PR Newswire
LONDON, United Kingdom, February 02
The Biotech Growth Trust PLC
02 February 2026
The Biotech Growth Trust PLC
Voting Rights and Capital
In accordance with the Financial Conduct Authority’s Disclosure Guidance and
Transparency Rules, The Biotech Growth Trust PLC (the «Company») announces the
following:
As at 31 January 2026, the Company capital consists of ordinary shares of 25p
with each ordinary share holding one voting right. The total number of ordinary
shares in issue is 20,747,975. The Company has no ordinary shares in Treasury.
Therefore, the total number of voting rights in the Company is 20,747,975.
The above figure (20,747,975) may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in the Company or a change to their interest in the Company,
under the Financial Conduct Authority’s Disclosure Guidance and Transparency
Rules.
– END –
Frostrow Capital LLP
Company Secretary
Tel: 0203 709 8734
This information was brought to you by Cision http://news.cision.com
